Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Health Evaluation in African Americans Using RAS Therapy
Authors not listed
Emory University · 2015
Abstract
The purpose of this study is to determine if telmisartan, an FDA approved blood pressure medication, may also have beneficial effects on Alzheimer's disease prevention in African Americans, who are at high risk for Alzheimer's disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-14 MST
Cite this
APA
Anonymous. (2015). Health Evaluation in African Americans Using RAS Therapy. <em>Emory University</em>. https://clinicaltrials.gov/study/NCT02471833
Vancouver
Anonymous. Health Evaluation in African Americans Using RAS Therapy. Emory University. 2015.
BibTeX
@misc{anon2015Health,
title = {Health Evaluation in African Americans Using RAS Therapy},
author = {Anonymous},
journal = {Emory University},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Neurobiology 2012
Citation only
Aβ Toxicity in Alzheimer's Disease
The Lancet 2021
Preprint · OA
Alzheimer's disease
Handbook of clinical neurology 2019
Citation only
Alzheimer's disease
Nature Reviews Neurology 2024
Preprint · OA
Is Alzheimer disease a disease?
International review of neurobiology 2019
Citation only
Dysfunction of mitochondria: Implications for Alzheimer's disease
Brain Research Reviews 2005
Citation only